gptkbp:instance_of
|
gptkb:virus
|
gptkbp:affects
|
gptkb:humans
cardiovascular issues
lung complications
post-viral fatigue
|
gptkbp:antigenic_properties
|
gptkb:hemagglutinin
gptkb:neuraminidase
|
gptkbp:associated_with
|
gptkb:Asian_flu_pandemic
|
gptkbp:cause
|
gptkb:virus
|
gptkbp:community_health
|
gptkb:quarantine_measures
|
gptkbp:community_impact
|
economic impact
healthcare burden
|
gptkbp:data_usage
|
R0 of 1.3 to 1.5
|
gptkbp:diagnosis
|
PCR testing
|
gptkbp:discovered_by
|
Dr. Thomas Francis Jr.
|
gptkbp:diseases
|
gptkb:swine_influenza
highly pathogenic
1957-1958
avian influenza
1957 Asian flu outbreak
1968 Hong Kong flu outbreak
Asian flu epidemic
|
gptkbp:genetic_studies
|
high mutation rate
antigenic drift
|
gptkbp:genus
|
gptkb:Orthomyxoviridae
|
gptkbp:historical_significance
|
first pandemic of the 20th century
|
https://www.w3.org/2000/01/rdf-schema#label
|
H2 N2 virus
|
gptkbp:is_monitored_by
|
global health organizations
|
gptkbp:is_recognized_as
|
gptkb:1957
|
gptkbp:is_vulnerable_to
|
inactivated vaccine
|
gptkbp:prevention
|
vaccination
|
gptkbp:propagation_method
|
airborne droplets
|
gptkbp:related_to
|
gptkb:H3_N2_virus
|
gptkbp:research_focus
|
vaccine development
public health preparedness
viral evolution
|
gptkbp:reservoir
|
gptkb:birds
|
gptkbp:responds_to
|
WHO guidelines
pandemic preparedness plans
|
gptkbp:risk_factor
|
age
pregnancy
underlying health conditions
immunocompromised status
|
gptkbp:scientific_classification
|
gptkb:virus
|
gptkbp:seed_dispersal
|
segmented RNA
|
gptkbp:symptoms
|
fatigue
cough
fever
sore throat
muscle aches
|
gptkbp:treatment
|
supportive care
antiviral medications
|
gptkbp:type_of
|
H2 N2
|
gptkbp:vaccine_developed_in
|
1960s
|
gptkbp:bfsParent
|
gptkb:Asian_flu_pandemic
|
gptkbp:bfsLayer
|
6
|